Skip to main content
FinSpry Logo
FinSpry
NAGE logo
NAGE
(NASDAQ)
Niagen Bioscience, Inc.
$3.21-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Niagen Bioscience (NAGE) Stock Price & Financial Analysis

Niagen Bioscience Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.14 - $3.24
52-Week High$10.52
52-Week Low$2.87
Open$3.17
Volume370.26K
Average Volume (3M)714.81K
Market Cap271.46M
Shares Outstanding84.57M
P/E Ratio (TTM)13.79
Forward P/E10.55
Price to Sales (P/S)1.97
Price to Book (P/B)3.12
EV/EBITDA12.76
Revenue (TTM)130.42M
Net Income (TTM)18.64M
Free Cash Flow (TTM)4.05M
EPS (TTM)$0.22
Profit Margin14.29%
Operating Margin8.51%
Return on Equity (ROE)22.64%
Debt to Equity0.03
50-Day MA$3.33
200-Day MA$4.93
52-Week Change-69.66%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Niagen Bioscience

What is the current stock price for NAGE?

As of the latest trading session, NAGE stock trades at $3.21. The 52-week range is $2.87–$10.52, with a day range of $3.14–$3.23.

What is the P/E ratio for NAGE?

Niagen Bioscience's trailing P/E ratio is 13.8, meaning investors pay $13.8 for every $1 of annual earnings. The forward P/E is 10.6, reflecting analyst expectations for future earnings. Niagen Bioscience operates in the Healthcare sector.

Does NAGE pay dividends?

Niagen Bioscience does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NAGE?

Based on 4 analysts, the consensus for NAGE is Buy.

What is the market cap of NAGE?

Niagen Bioscience's market capitalization is $271.5M, classifying it as a micro-cap company. Niagen Bioscience operates in the Healthcare sector within the Biotechnology industry.